← Back
$LGND All transactions

LIGAND PHARMACEUTICALS INC

A

$ Value

$0

Shares

21,525

Price

$0

Filed

Mar 27

Insider

Name

Reardon Andrew

Title

CLO & Secretary

CIK

0001950232

Roles

Officer

Transaction Details

Transaction Date

2026-03-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

21,525

Footnotes

Represents restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three substantially equal annual installments on February 15, 2027, February 15, 2028 and February 15, 2029, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Pursuant to an election under the Issuer's Nonqualified Deferred Compensation Plan, delivery of shares otherwise issuable upon each vesting date will be deferred. | The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.

Filing Info

Accession No.

0002001011-26-000032

Form Type

4

Issuer CIK

0000886163

Reardon Andrew's History

Date Ticker Type Value
2026-04-01 LGND M $261K
2026-04-01 LGND $91K
2026-04-01 LGND $260K
2026-04-01 LGND $249K
2026-04-01 LGND $141K
2026-04-01 LGND $196K
2026-04-01 LGND $69K
2026-04-01 LGND M $0
2026-03-02 LGND A $0
2026-03-02 LGND A $0

Other Insiders at LGND (90d)

Insider Bought Sold Last
LAMATTINA JOHN L $434K 2026-03-06
KOZARICH JOHN W $94K 2026-04-01
Davis Todd C
Chief Executive Officer
2026-03-02
Sabba Stephen L $208K 2026-03-23
Espinoza Octavio
Chief Financial Officer
2026-03-02
Reardon Andrew
CLO & Secretary
$1.0M 2026-04-01